Canavan disease is a rare genetic disorder that damages the brain’s nerve tissue over time. It belongs to a group of conditions called leukodystrophies, which affect the protective covering of nerve cells. This article explains what Canavan disease is, who it affects, and what families in Canada can expect when it comes to diagnosis and care.
What Is Canavan Disease?
Canavan disease is a progressive neurological condition. That means it gets worse over time, gradually destroying brain tissue. It is one of the most severe inherited brain disorders in children.
The disease is part of a broader group called leukodystrophies. These are rare genetic conditions that damage the white matter of the brain — the tissue that helps nerve signals travel properly. As a result, the brain loses its ability to send and receive messages correctly.
Over time, the brain tissue becomes soft and spongy, filled with tiny fluid-filled spaces. This damage affects movement, development, and many basic body functions. For more background on rare neurological conditions, visit Health Canada’s rare disease resources.
Types of Canavan Disease
There are two main forms of Canavan disease. They differ in when symptoms appear and how severe the condition becomes.
Infantile Canavan Disease
This is the most common and most serious form. Symptoms appear before a child reaches one year of age. Most children with infantile Canavan disease survive into childhood or adolescence, but they face serious health challenges throughout their lives.
Symptoms worsen significantly around age 10. At that stage, the condition can become life-threatening. Children may develop complications affecting breathing, swallowing, and muscle control.
Juvenile Canavan Disease
This form appears later in childhood and is much rarer. It is also less severe. Children with juvenile Canavan disease may have mild developmental delays and speech difficulties. However, this form does not appear to significantly shorten a person’s lifespan.
What Causes Canavan Disease?
Canavan disease is caused by a genetic mutation — a change in the structure of a specific gene. This mutation is inherited, meaning it is passed down from parents to their children.
The affected gene is responsible for producing an enzyme called aspartoacylase (ASPA). This enzyme normally breaks down a brain chemical called N-acetylaspartate (NAA). Without enough ASPA, NAA builds up in the brain.
Too much NAA destroys the myelin sheath — the protective coating around nerve cells in the brain and spinal cord. Think of myelin like the plastic coating around an electrical wire. Without it, signals cannot travel properly. Over time, the brain tissue breaks down and becomes spongy, which prevents normal brain function.
Canavan disease follows an autosomal recessive pattern. This means a child must inherit one mutated gene from each parent to develop the disease. Parents who each carry one copy of the mutation usually have no symptoms themselves. However, each pregnancy carries a 25% chance of the child having the condition. You can learn more about how genetic conditions are inherited at the Mayo Clinic’s guide to genetic disorders.
Signs and Symptoms of Canavan Disease
In most cases, signs of infantile Canavan disease appear between 3 and 6 months of age. Parents often notice that their baby is not meeting typical developmental milestones.
Early Signs to Watch For
Weak or stiff muscle tone (the baby feels unusually floppy or rigid)
An abnormally large head (called macrocephaly) that is difficult to lift or control
Delays in sitting up, crawling, walking, or talking
Difficulty feeding or swallowing
Poor motor control and limited movement
Quiet, unresponsive behaviour with little emotional reaction — the child may seem apathetic
These early signs can be easy to miss or confuse with other conditions. Therefore, it is important to speak with your family doctor if your baby is not reaching milestones on time.
Severe Symptoms in Later Stages
As Canavan disease progresses, symptoms become more serious. Children with the infantile form often experience a significant decline around age 10.
Hearing loss or complete deafness
Significant intellectual disability
Muscle spasms, including in the muscles used for breathing
Severe swallowing difficulties
Vision loss
Children with juvenile Canavan disease typically experience milder symptoms. These may include speech delays, some difficulty with school tasks, and minor developmental differences. In addition, their symptoms do not usually become life-threatening.
How Is Canavan Disease Diagnosed?
Diagnosing Canavan disease involves several steps. Your child’s paediatrician will likely refer your family to a specialist in medical genetics if Canavan disease is suspected.
Tests Used to Diagnose Canavan Disease
Blood and urine tests: These measure the level of NAA in the body. High levels suggest Canavan disease. Genetic tests can also identify the specific mutation.
Fibroblast cell testing: This test analyses skin cells called fibroblasts to measure ASPA enzyme activity.
MRI brain scan: An MRI shows changes in the brain’s white matter, which helps confirm the diagnosis.
Prenatal Testing Options
Canavan disease can be detected before birth. If you have a family history of the condition or are a known carrier, your doctor may recommend prenatal testing.
Amniocentesis: This test analyses fluid from the amniotic sac. It is typically performed between weeks 15 and 20 of pregnancy.
Chorionic villus sampling (CVS): This test examines a small piece of placenta tissue. It can be done earlier, between weeks 10 and 12 of pregnancy.
Genetic counselling is strongly recommended for families with a known risk. A genetic counsellor can help you understand your options and make informed decisions about your family’s health. Many provincial health plans in Canada cover referrals to medical genetics programmes. Ask your family doctor about accessing these services in your province.
Treatment Options for Canavan Disease
Unfortunately, there is currently no cure for Canavan disease. However, several treatments can help manage symptoms and improve quality of life. Early support makes a meaningful difference for both children and their families.
Managing Symptoms Day to Day
Nutritional support: Children who cannot swallow safely may need tube feeding to stay nourished and hydrated.
Anti-seizure medications: These help control neurological symptoms and seizures.
Physiotherapy: Regular physiotherapy helps maintain posture, improve muscle function, and support movement for as long as possible.
Speech therapy: This can help with communication and swallowing difficulties.
Occupational therapy: Occupational therapists help children and families adapt daily routines to the child’s abilities.
Families caring for a child with Canavan disease often benefit from connecting with a multidisciplinary care team. In Canada, children’s hospitals in major centres like Toronto, Vancouver, Montreal, and Calgary offer specialised neurology and genetics programmes. Your family doctor or paediatrician can help coordinate a referral.
Emerging Research
Researchers are actively studying gene therapy as a potential future treatment for Canavan disease. Early clinical trials have shown some promise. For the latest information on research developments, visit Healthline’s overview of Canavan disease research.
Complications of Canavan Disease
Canavan disease causes serious complications as it progresses. These affect nearly every area of a child’s development and daily life.
Motor complications are common. Children often have great difficulty lifting their heads, sitting, crawling, or walking. Muscle stiffness and spasms can make movement painful and difficult.
Swallowing problems create significant nutrition and safety risks. As the disease advances, children may not be able to eat or drink by mouth safely. This increases the risk of aspiration — when food or liquid enters the lungs.
Developmental delays affect communication, learning, and social interaction. Language skills may develop very late or not at all. Furthermore, intellectual disabilities become more pronounced over time in children with the infantile form.
When to See a Doctor
If you notice that your baby or young child is not reaching developmental milestones, speak with your family doctor as soon as possible. Early assessment is important. You do not need to wait for a specialist referral — start by booking an appointment with your family doctor or visiting a walk-in clinic.
Signs that warrant prompt medical attention include a very large head that the baby cannot lift, unusual muscle weakness or stiffness, and feeding difficulties in an infant. These may not always point to Canavan disease, but they deserve proper evaluation.
If your family has a known history of Canavan disease or leukodystrophy, speak with your doctor before or during pregnancy. Genetic counselling is available through many provincial health plans and can help you understand your risk and your options.
Always consult a qualified healthcare provider for any concerns about your child’s health. The information in this article is for general education only and does not replace professional medical advice.
Frequently Asked Questions About Canavan Disease
What is Canavan disease and how rare is it?
Canavan disease is a rare inherited genetic disorder that progressively destroys brain tissue. It affects roughly 1 in 6,400 to 13,500 people in certain populations, particularly those of Ashkenazi Jewish descent. It is considered a rare disease in the general Canadian population.
Is Canavan disease fatal?
The infantile form of Canavan disease is life-limiting. Most children with this form survive into childhood or adolescence, but the disease significantly affects their quality of life and longevity. The juvenile form is less severe and does not appear to shorten lifespan significantly.
Can Canavan disease be detected before birth?
Yes, Canavan disease can be identified before birth through prenatal tests such as amniocentesis or chorionic villus sampling (CVS). These tests are recommended for parents who carry the genetic mutation or have a family history of the condition. Genetic counselling can help families decide whether prenatal testing is right for them.
Is there a cure for Canavan disease?
Currently, there is no cure for Canavan disease. Treatment focuses on managing symptoms, improving comfort, and supporting the child’s development for as long as possible. Gene therapy research is ongoing and may offer hope for future treatments.
What causes Canavan disease?
Canavan disease is caused by a mutation in the gene that produces the enzyme aspartoacylase (ASPA). Without enough ASPA, a brain chemical called N-acetylaspartate builds up and destroys the myelin sheath surrounding nerve cells. Both parents must carry the mutated gene for a child to develop the disease.
How is Canavan disease different from other leukodystrophies?
Canavan disease is one of many leukodystrophies, but it is specifically caused by ASPA enzyme deficiency and the resulting buildup of N-acetylaspartate. Other leukodystrophies involve different genes and enzymes, leading to different patterns of symptoms and progression. A specialist in medical genetics can help distinguish between these rare conditions.
Key Takeaways
Canavan disease is a rare, inherited genetic disorder that progressively damages brain tissue.
It is caused by a mutation in the gene that produces the ASPA enzyme, leading to a toxic buildup of NAA in the brain.
The infantile form is the most common and most serious, with symptoms appearing before age one.
The juvenile form is milder and does not significantly shorten lifespan.
There is currently no cure, but physiotherapy, medication, and nutritional support can help manage symptoms.
Families with a known risk should ask their family doctor about genetic counselling, which is available through many provincial health plans in Canada.
If your baby is missing developmental milestones, speak with your family doctor or visit a walk-in clinic promptly.
